Please reload

Recent Posts

I'm busy working on my blog posts. Watch this space!

Please reload

Featured Posts

Two stocks could change your portfolio outlook colour from red to green

February 23, 2018

FATE THERAPEUTICS INC COM FATE NSDQ
Healthcare : Biotechnology & Medical Research



On 02/20/2018  Fate Therapeutics Announces First Subject Treated with FATE-NK100 in DIMENSION Study for Advanced Solid Tumors . First Clinical Trial Investigating the Combination of Allogeneic Donor NK Cell Therapy and FDA-Approved Targeted Monoclonal Antibody Therapy for Solid Tumor Malignancies. FATE stock has approved since Sep 2017 the great advantage of own this type of growth invest. The world wide market need cancer monoclonal antibodies with about 30 billion $ and more for the next five years .
My rate for this great stock is Buy/strong hold. Good entry might be between 8.75 and 9.50 The price target for this is 12.50 $ for the next 20 days.


CELSION CORPORATION COM PAR NEW CLSN: NASDAQ Healthcare : Biotechnology & Medical Research


On 18 Jan 2018  the Company  announced the Advances ThermoDox® for Treatment of Primary Liver Cancer Following Independent Data Monitoring Committee's Unanimous Recommendation to Continue Phase III OPTIMA Study OPTIMA Study Enrollment Reached 74% Enrollment at Year-End, With Enrollment Completion Expected in Third Quarter 2018 Initiation of Enrollment of Phase I Portion of OVATION II Study of GEN-1 for Treatment of Ovarian Cancer Anticipated in the First Half of 2018 Cash Position of $25.5 Million at Year-End 2017 Provides Runway to Advance Development Priorities into Third Quarter of 2019 .
With this sentences, CELSION corporation mentioned their Update and 2018 Outlook. Traders usually like the advantage of low float and small-cap company, this stock could be among the winners for this year for both swing and long traders. My rate for this stock is Strong Buy /Strong Hold any entry between 1.90 $ and 2.20 looks very promising.For swing, short term price target is 2.75 $ for the next 15 days, for Med short-term price target is 3.50 $ within 45 days.

Important note :I am uncertified technical chart analysis and I do not have any insider trading or position at this stock, you own your decision to buy, hold or sell this stock.

How I became a successful trader this is the simple answer visit this if you interested to be too https://tinyurl.com/y8pq9496 .

 

 

Share on Facebook
Share on Twitter
Please reload

Follow Us

I'm busy working on my blog posts. Watch this space!

Please reload

Search By Tags
Please reload

Archive
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

© 2023 by Success Consulting. Proudly created with Wix.com.